By Angus Liu
Scientists have linked chronic inflammation and regulatory T cells together in pinpointing a potential new drug target for colorectal cancer. The findings point to drugs like Amgen and AstraZeneca's newly approved tezepelumab as a possible treatment for the disease.
read more
By Heather Landi
Kyle Robertson, a co-founder of embattled startup Cerebral, has stepped down from the CEO role, effective immediately, the company announced Wednesday.
read more
By Max Bayer
Merck & Co. is plucking a cancer project from the branch of Chinese-based Kelun Pharmaceutical for up to $1.4 billion, but details from the New Jersey-based Big Pharma have been hard to come by.
read more
By Andrea Park
While it may seem that there’s no clear rhyme or reason to long COVID diagnoses, researchers from the National Institutes of Health are determined to suss out a pattern that could shed at least a little light on the factors that put a person at higher risk of developing the condition.
read more
By Angus Liu
After 50 years establishing itself as one of the largest pharma companies in China, Jiangsu Hengrui Pharmaceuticals is launching Luzsana Biotechnology for the global market. With a unique operating model, the subsidiary aims to “quantifiably reduce costs” of medicines, its CEO said, starting with a PD-1 cancer immunotherapy.
read more
By Annalee Armstrong
“We just don’t have the studies” became a familiar refrain for Kirsten Bibbins-Domingo, M.D., Ph.D., chair of the Committee on Improving Representation of Women and Underrepresented Minorities in Clinical Trials and Research. A new report from the committee shines a light on the “critical shortcoming” in clinical research conducted in the U.S.: a lack of representation in clinical trials.
read more
By Paige Minemyer
Humana's CenterWell and Welsh, Carson, Anderson and Stowe are teaming for a second joint venture focused on value-based primary care.
read more
By Andrea Park
After proving that its blood test to measure the level of amyloid plaques in the brain matches up to the results of PET scans in predicting the onset of Alzheimer’s disease, C2N Diagnostics is expanding its slate of Alzheimer’s screening tools.
read more
By Ben Adams
Danish pharma Novo Nordisk is running a new unbranded awareness campaign aimed at younger people struggling with obesity with a focus on not making them feel it is up to them alone to lose weight.
read more
By James Waldron,Annalee Armstrong
Life sciences VC firm Flagship Pioneering has unveiled a new company called Sonata Therapeutics to develop cell signaling therapies for oncology, fibrosis, and autoimmune disorders. Flagship founded Sonata this year by combining two of the VC’s existing ventures: Inzen Therapeutics and Cygnal Therapeutics.
read more
By Angus Liu
Roche and gene therapy rival bluebird bio are settling a short-lived trademark infringement lawsuit around the latter company's sickle cell disease awareness campaign.
read more
By Conor Hale
The Inhance system previously received a green light for anatomic arthroplasty—where the implant mimics the shoulder’s natural ball-and-socket structure. Now it works both ways.
read more
By Dave Muoio
Unveiled in 2020, the two New Jersey health systems' deal looks to form the state's first "premier academic medical center."
read more
